| VD | Vitamin D |
| MySLR | My Systematic Literature Review |
| LDA | Latent Dirichlet Allocation (algorithm for topic modeling) |
| NRS | Numeric Rating Scale |
| VAS | Visual Analog Scale |
| BPI | Brief Pain Inventory |
| BPI-SF | Brief Pain Inventory–Short Form |
| MODQ | Modified Oswestry Disability Questionnaire |
| MNSI | Michigan Neuropathy Screening Instrument |
| WOMAC | Western Ontario and McMaster Universities Osteoarthritis Index |
| CIPN | Chemotherapy-induced peripheral neuropathy |
| CIPN20 | Chemotherapy-Induced Peripheral Neuropathy 20-item Quality of Life Questionnaire |
| FIQ | Fibromyalgia Impact Questionnaire |
| HAQ | Health Assessment Questionnaire |
| HAQ-DI | Health Assessment Questionnaire–Disability Index |
| AI | Aromatase inhibitor |
| AIMSS | Aromatase Inhibitor-Associated Musculoskeletal Symptom |
| PL | Placebo |
| IU | International Units |
| 25(OH)D | 25-hydroxyvitamin D (a marker for Vitamin D status) |
| NP | Neuropathic pain |
| CWP | Chronic widespread pain |
| NAAA | N-Acylethanolamine acid amidase |
| SRE | Summary Risk of Bias Evaluation |